Lupin has announced the completion of its acquisition of VISUfarma, a European specialty pharmaceutical company focused on ophthalmology, from GHO Capital Partners LLP (GHO).
Adragos Pharma, a global contract development and manufacturing organisation (CDMO), has announced that it completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi.
Samsung Biologics has announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States.
Verista explores how shifting to “governance as code,” starting with practical automation of core controls, adopting risk-based AI classification, and cultivating a new generation of governance specialists can help organisations close that gap.
Bracco Imaging announced an upgrade of its manufacturing site in Geneva to support clinical-grade GMP manufacturing of its cell therapy-enabling microbubble technology, building on its previously announced Investments in the site since 2019.
Ampacet has introduced ProVital+ Gamma-Protect, a medical-grade additive designed to preserve mechanical and optical properties of polypropylene-based medical and pharmaceutical articles during gamma and e-beam sterilisation processes.
Mark Woolf, chief operating officer, COREX After 14 years of managing pharma logistics exclusively in CIS and Eastern European markets, Mark Woolf, COO of COREX, has seen the same misconceptions trip up Western pharma companies time and again.
Critical Manufacturing, the Industrial Operations Platform company that unites execution, connectivity, analytics and trusted AI, will exhibit at Hannover Messe, demonstrating how manufacturers can transform production complexity into operations.
